Ticker
SANACompany Name
SANA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 694.39M | $ 4.32M | $ 116K | $ 0 | -0.64% |
3/31/2025 | $ 408.26M | $ 6.67M | $ 7.66M | $ 0 | -3.51% |
12/31/2024 | $ 623.32M | $ 192M | $ 7.74M | $ 0 | -32.05% |
9/30/2024 | $ 670.92M | $ 193.02M | $ 7.8M | $ 0 | -29.93% |
6/30/2024 | $ 1.04B | $ 191.3M | $ 7.63M | $ 0 | -19.19% |
3/31/2024 | $ 2.1B | $ 217.81M | $ 0 | $ 0 | -10.36% |
12/31/2023 | $ 2.21B | $ 31.65M | $ 0 | $ 0 | -1.43% |
9/30/2023 | $ 658.42M | $ 30.99M | $ 0 | $ 0 | -4.71% |
6/30/2023 | $ 1.07B | $ 32.42M | $ 0 | $ 0 | -3.03% |
3/31/2023 | $ 1.06B | $ 4.5M | $ 0 | $ 0 | -0.42% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for SANA BIOTECHNOLOGY INC is calculated as follows: (-1 * CF - Equity [ $ 1K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |